Who is sponsoring NCT04156061?

NCT04156061 is sponsored by University of Edinburgh.

What drugs are being tested in NCT04156061?

Interventions in NCT04156061: Delivery of CT scan results.

What condition does NCT04156061 study?

NCT04156061 studies Coronary Artery Disease, Primary Prevention.

Is NCT04156061 still recruiting?

NCT04156061 is currently active, enrolled. Last updated 18 November 2025.

Last reviewed 2025-11-18 · How we verify

NCT04156061

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of the SCOT-HEART 2 Trial on Lifestyle.

Active, enrolled NA Last updated 18 November 2025

What this trial tests

NA trial testing Delivery of CT scan results in Coronary Artery Disease in 400 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

28 September 2020

Primary endpoint
12 January 2024

7 July 2027

Quick facts

Lead sponsor	University of Edinburgh
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	400
Start date	28 September 2020
Primary completion	12 January 2024
Estimated completion	7 July 2027
Sites	1 location across United Kingdom

Drugs / interventions tested

Delivery of CT scan results

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →
Primary Prevention — all drugs for Primary Prevention →

Sponsor

University of Edinburgh

Who can join

Adults 40 to 70, any sex, with Coronary Artery Disease or Primary Prevention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will recruit 400 participants who are taking part in the Computed Tomography Coronary Angiography for the Prevention of Myocardial Infarction (SCOT-HEART 2) trial. The investigator will assess diet, activity and habits at the start of the study and 6 months later. This will help us understand the effects taking part in the study may have on lifestyle. In addition, for participants who have CT scans, the investigator will present the results of the heart from the CT scan. This will help us understand how best to explain the results of the CT scan to patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Screening for occult coronary artery disease in potential kidney transplant recipients: time for reappraisal?
Ferro CJ, Berry M, Moody WE, George S, et al · · 2021 · cited 7× · PMID 34950460 · DOI 10.1093/ckj/sfab103

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other University of Edinburgh trials

Trials by the same sponsor.

NCT07341126 — Use of a Novel Camera to Check the Bowel After Polyp or Tumour Removal · not yet recruiting
NCT07523997 — Imaging of Endometriosis With Total-body PET-CT (PET-Endo) · not yet recruiting
NCT07430540 — Optimising Colorectal Cancer Patient Pathways · NA · not yet recruiting
NCT07430527 — Secondary Care Colorectal Cancer Pathway Review · not yet recruiting
NCT07436026 — Latin America Network for Primary Palliative Care · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04156061 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Edinburgh
Last refreshed: 18 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04156061.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing